Cargando…
Molecular docking-based screening of methicillin-resistant Staphylococcus aureus FEM proteins with FDA-approved drugs
Antibiotic resistance stands as one of the most significant public health challenges in recent decades. FEM proteins are responsible for the synthesis of pentaglycine cross-bridge, a primary constituent of bacterial peptidoglycan polymer crosslinking during cell wall biosynthesis. Since they are nec...
Autores principales: | Akkiraju, Anjini Gayatri, Badugu, Aishwaraya, Das, Aditi, Sagurthi, Someswar Rao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692981/ https://www.ncbi.nlm.nih.gov/pubmed/38046517 http://dx.doi.org/10.6026/973206300191035 |
Ejemplares similares
-
Resensitization of methicillin-resistant Staphylococcus aureus by amoxapine, an FDA-approved antidepressant
por: Wilson, Tyler J., et al.
Publicado: (2018) -
Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus
por: Sharma, Amar Deep, et al.
Publicado: (2022) -
Synthesis, antimicrobial and antioxidant activity of triazole, pyrazole containing thiazole derivatives and molecular docking studies on COVID-19
por: Matta, Raghavender, et al.
Publicado: (2023) -
Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus
por: Hagihara, Mao, et al.
Publicado: (2012) -
The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus
por: Yeo, Won-Sik, et al.
Publicado: (2018)